Genetics of epilepsy

Journal of Child Neurology

Volumn 17, Issue SUPPL. 1, 2002, Pages

  Willmore, L James ^a   Ueda, Yuto ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN FUNCTION; BRAIN MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; EPILEPSY; EPILEPTOGENESIS; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GENETIC COUNSELING; GENETIC DISORDER; GENETIC STABILITY; GENETIC TRAIT; HUMAN; IDIOPATHIC DISEASE; INHERITANCE; MEDICAL RESEARCH; MOLECULAR BIOLOGY; MYOCLONUS EPILEPSY; NEUROLOGIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; REMISSION; SEIZURE;

EID: 0036237952     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738020170010301     Document Type: Article

References (137)

1. Proposal for classification of epilepsies and epileptic syndromes
2. Proposal for revised clinical and electroencephalographic classification of epileptic seizures
3. Genome scan of idiopathic generalized epilepsy: Evidence for major susceptibility gene and modifying genes influencing the seizure type
4. Benign familial neonatal seizures: Clinical and electroencephalographic characteristics
5. Familial neonatal and infantile seizures: An autosomal-dominant disorder
6. Benign neonatal convulsions linked to genetic markers on chromosome 20
7. Phenotypic expression of benign familial neonatal convulsions linked to chromosome 20
8. Genetic heterogeneity in benign familial neonatal convulsions: Identification of a new locus on chromosome 8q
9. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family
10. A potassium channel mutation in neonatal human epilepsy
11. A novel potassium channel gene, KCNQ2, is mutated in inherited epilepsy of newborns
12. +-channel beta1 subunit gene SCN1B
13. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
14. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome
15. + channels causes epilepsy
16. + channels
17. +-selective pore of the K(in) channel KAT1
18. + channel IRK1 and its point mutant (Q140E) in the pore region
19. Benign epilepsies of infancy
20. Benign infantile epilepsy with complex partial seizures
21. Benign infantile familial convulsions
22. Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q
23. Benign infantile familial convulsions are not an allelic form of the benign familial neonatal convulsions gene
24. Pediatric epilepsy syndromes: An overview
25. The long-term course of primary generalized epilepsy with persisting absences
26. Long-term prognosis of typical childhood absence epilepsy: Remission or progression to juvenile myoclonic epilepsy
27. Genetics of convulsive disorders, I: Introduction, problems, methods and baselines
28. Genetics of convulsive disorders, II: Genetics and electroencephalographic studies in centrencephalic epilepsy
29. Epilepsies in twins: Genetics of the major epilepsy syndromes
30. Some genetic aspects of idiopathic and symptomatic absence seizures: Waking and sleep EEGs in siblings
31. Idiopathic epilepsies with a complex mode of inheritance
32. Childhood absence epilepsy with tonic-clonic seizures and electroencephalogram 3-4 Hz spike and multispike-slow-wave complexes: Linkage to chromosome 8q24
33. Mapping and positional cloning of common idiopathic generalized epilepsies: Juvenile myoclonus epilepsy and childhood absence epilepsy
34. Absence epilepsies
35. Therapeutic response of absence seizures in patients of an epilepsy clinic for adolescents and adults
36. Allelic association of juvenile absence epilepsy with a GluR5 kainate receptor gene (GRIK1) polymorphism
37. Juvenile myoclonic epilepsy: An autosomal recessive disease
38. On the genetics of the primary generalized epilepsy with sporadic myoclonias of impulsive petit mal type: A clinical and electroencephalographic study of 399 probands
39. Multifactorial inheritance of generalized and focal epilepsy
40. Segregation analysis of juvenile myoclonic epilepsy
41. Gene mapping in the idiopathic generalized epilepsies: Juvenile myoclonic epilepsy, childhood absence epilepsy, epilepsy with grand mal seizures, and early childhood myoclonic epilepsy
42. Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6
43. Juvenile myoclonic epilepsy locus in chromosome 6p21.2-p11: Linkage to convulsions and electroencephalography trait
44. Confirmation of linkage between juvenile myoclonic epilepsy locus and the HLA region of chromosome 6
45. Refined mapping of the epilepsy susceptibility locus EJM1 on chromosome 6
46. Localization of idiopathic generalized epilepsy on chromosome 6p in families of juvenile myoclonic epilepsy patients
47. Linkage analysis of idiopathic generalized epilepsy (IGE) and marker loci on chromosome 6p in families of patients with juvenile myoclonic epilepsy: No evidence for an epilepsy locus in the HLA region
48. Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q
49. Mapping of genes predisposing to idiopathic generalized epilepsy
50. Replication analysis of a putative susceptibility locus (EGI) for idiopathic generalized epilepsy on chromosome 8q24
51. Genetic localization of the familial adult myoclonic epilepsy (FAME) gene to chromosome 8q24
52. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q13.2
53. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy
54. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy
55. Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization
56. An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics
57. 2+ permeability, conductance, and gating of human α4β2 nicotinic acetylcholine receptors
58. Autosomal dominant nocturnal frontal-lobe epilepsy: Genetic heterogeneity and evidence for a second locus at 15q24
59. Epilepsies with single gene inheritance
60. Autosomal dominant frontal lobe epilepsy misdiagnosed as sleep disorder
61. Autosomal dominant nocturnal frontal epilepsy: A distinctive clinical disorder
62. Refinement of the localization of the gene for neuronal nicotinic acetylcholine receptor alpha4 subunit (CHRNA4) to human chromosome 20q13.2-13.3
63. The clinical pharmacokinetics of the newer antiepileptic drugs
64. Prognosis of benign childhood epilepsy with centrotemporal spikes: A follow-up study of 168 patients
65. Spike morphology in childhood focal epilepsy: Relationship to syndromic classification
66. Dipole reversal: An ictal feature of benign partial epilepsy with centrotemporal spikes
67. Evidence for a genetic aetiology of temporal central abnormalities in focal epilepsy
68. Centrotemporal spikes in families with rolandic epilepsy: Linkage to chromosome 15q14
69. Autosomal dominant rolandic epilepsy and speech dyspraxia: A new syndrome with anticipation
70. Familial temporal lobe epilepsy: A common disorder identified in twins
71. Localization of a gene for partial epilepsy to chromosome 10q
72. Autosomal dominant partial epilepsy with auditory features: Defining the phenotype
73. Autosomal dominant partial epilepsy with auditory features: Description of a new family
74. Familial partial epilepsy with variable foci: A new partial epilepsy syndrome with suggestion of linkage to chromosome 2
75. Febrile convulsions in a national cohort followed up from birth. I-Prevalence and recurrence in the first five years of life
76. Prognosis of children with febrile seizures
77. Febrile convulsions in 220 children-Neurological sequelae at 12 years follow-up
78. Risk factors for a first febrile seizure: A matched case-control study
79. Prenatal and perinatal antecedents of febrile seizures
80. The occurrence of epilepsy and febrile seizures in Virginian and Norwegian twins
81. Hereditary febrile seizures: Phenotype and evidence for a chromosome 19p locus
82. A locus for febrile seizures (FEB3) maps to chromosome 2q23-24
83. Generalized epilepsy with febrile seizures plus: A genetic disorder with heterogeneous clinical phenotypes
84. A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33
85. Mapping a locus for idiopathic epilepsy in a large multiplex family
86. + channel beta 1 subunit gene (SCN1B)
87. Regions of sex-specific hypo- and hyper-recombination identified through integration of 180 genetic markers into the metric physical map of human chromosome 19
88. Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel
89. + channel beta 1 subunit mRNA expressed in adult human skeletal muscle, heart, and brain is encoded by a single gene
90. Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+) on chromosome 2q24-q33
91. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus
92. + channels
93. + channel function in the extracellular domain of the beta 1 subunit
94. Lissencephaly and other malformations of cortical development: 1995 update
95. Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor
96. Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome
97. X-linked malformations of neuronal migration
98. A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar heterotopia and lissencephaly syndrome
99. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein
100. 2+-dependent signaling protein which is mutated in human X-linked neuronal migration defects
101. Periventricular heterotopia and epilepsy
102. Periventricular heterotopia: An X-linked dominant epilepsy locus causing aberrant cerebral cortical development
103. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia
104. Progressive myoclonus epilepsies: Clinical and genetic aspects
105. Progressive myoclonus epilepsy: Genetic and nosological aspects with special reference to 107 Finnish patients
106. Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22
107. Linkage studies in progressive myoclonus epilepsy: Unverricht-Lundborg and Lafora's diseases
108. Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1)
109. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)
110. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy EPM1
111. Familial mitochondrial encephalomyopathy (MERRF): Genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease
112. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy
113. The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q
114. A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2)
115. Epileptic phenotypes associated with mitochondrial disorders
116. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA (Lys) mutation
117. A new mtDNA mutation in the tRNA (Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF)
118. MELAS syndrome: Characteristic migrainous and epileptic features and maternal transmission
119. Mitochondrial myopathies
120. The elusive transporters with a high affinity for glutamate
121. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
122. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1
123. Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration
124. Alterations in glutamate transporter protein levels in kindling-induced epilepsy
125. Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity
126. Inhibition of synthesis of EAAC-1 glutamate transporter alters gamma-aminobutyric acid levels in discrete brain regions, abstract
127. Family of neural and acidic amino acid transporters: Molecular biology, physiology and medical implications
128. Collapse of extracellular glutamate regulation during epileptogenesis: Down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid
129. 3+-induced epileptogenesis
130. Cloning and expression of a rat brain GABA transporter
131. Purification and identification of the functional sodium- and chloride-coupled gamma-aminobutyric acid transport glycoprotein from rat brain
132. Sodium valproate decreases synaptic potentiation and epileptiform activity in hippocampus
133. Valproic acid suppresses the synaptic response mediated by the NMDA receptors in rat amygdalar slices
134. Valproate suppresses N-methyl-D-aspartate-evoked, transient depolarizations in the rat neocortex in vitro
135. Molecular regulation of glutamate and GABA transporter proteins by valproic acid in rat hippocampus during epileptogenesis